218 related articles for article (PubMed ID: 28850688)
21. Outcome, complications and future fertility in women treated with uterine artery embolization and methotrexate for non-tubal ectopic pregnancy.
Krissi H; Hiersch L; Stolovitch N; Nitke S; Wiznitzer A; Peled Y
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():172-6. PubMed ID: 25300059
[TBL] [Abstract][Full Text] [Related]
22. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy?
Gabbur N; Sherer DM; Hellmann M; Abdelmalek E; Phillip P; Abulafia O
Am J Perinatol; 2006 Apr; 23(3):193-6. PubMed ID: 16586235
[TBL] [Abstract][Full Text] [Related]
23. The importance of β-hCG values in prediction of the effectiveness of single dose methotrexate therapy in tubal ectopic pregnancy.
Yıldız A; Bilge O
Ginekol Pol; 2023; 94(4):303-308. PubMed ID: 35315015
[TBL] [Abstract][Full Text] [Related]
24. A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy.
Sowter MC; Farquhar CM; Petrie KJ; Gudex G
BJOG; 2001 Feb; 108(2):192-203. PubMed ID: 11236120
[TBL] [Abstract][Full Text] [Related]
25. Predictors of methotrexate treatment failure in ectopic pregnancy.
Dilbaz S; Caliskan E; Dilbaz B; Degirmenci O; Haberal A
J Reprod Med; 2006 Feb; 51(2):87-93. PubMed ID: 16572908
[TBL] [Abstract][Full Text] [Related]
26. Predictors of success in methotrexate treatment of women with unruptured tubal pregnancies.
Nazac A; Gervaise A; Bouyer J; de Tayrac R; Capella-Allouc S; Fernandez H
Ultrasound Obstet Gynecol; 2003 Feb; 21(2):181-5. PubMed ID: 12601843
[TBL] [Abstract][Full Text] [Related]
27. Nonsurgical management of live tubal ectopic pregnancy by ultrasound-guided local injection and systemic methotrexate.
Wang M; Chen B; Wang J; Ma X; Wang Y
J Minim Invasive Gynecol; 2014; 21(4):642-9. PubMed ID: 24462855
[TBL] [Abstract][Full Text] [Related]
28. Early prediction of methotrexate treatment outcome in tubal ectopic pregnancy based on days 0 and 4 human chorionic gonadotropin levels.
Shatkin Hamish N; Wolf M; Tendler R; Sharon A; Bornstein J; Odeh M
J Obstet Gynaecol Res; 2020 Jul; 46(7):1104-1109. PubMed ID: 32406562
[TBL] [Abstract][Full Text] [Related]
29. Comparison of single and multiple dose methotrexate therapy for unruptured tubal ectopic pregnancy: a prospective randomized study.
Guvendag Guven ES; Dilbaz S; Dilbaz B; Aykan Yildirim B; Akdag D; Haberal A
Acta Obstet Gynecol Scand; 2010 Jul; 89(7):889-95. PubMed ID: 20583934
[TBL] [Abstract][Full Text] [Related]
30. Treatment of unruptured tubal pregnancy by local injection of methotrexate under transvaginal sonographic control.
Ménard A; Créquat J; Mandelbrot L; Hauuy JP; Madelenat P
Fertil Steril; 1990 Jul; 54(1):47-50. PubMed ID: 1694146
[TBL] [Abstract][Full Text] [Related]
31. Medical treatment of ruptured with hemodynamically stable and unruptured ectopic pregnancy patients.
Kumtepe Y; Kadanali S
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):221-5. PubMed ID: 15358469
[TBL] [Abstract][Full Text] [Related]
32. Presence of a yolk sac on transvaginal sonography is the most reliable predictor of single-dose methotrexate treatment failure in ectopic pregnancy.
Bixby S; Tello R; Kuligowska E
J Ultrasound Med; 2005 May; 24(5):591-8. PubMed ID: 15840789
[TBL] [Abstract][Full Text] [Related]
33. Conservative management of interstitial pregnancies: experience of a single centre.
Uludag SZ; Kutuk MS; Dolanbay M; Ozgun MT; Eliyeva G; Altun O
J Obstet Gynaecol; 2018 Aug; 38(6):848-853. PubMed ID: 29537335
[TBL] [Abstract][Full Text] [Related]
34. Unruptured tubal pregnancy: local low-dose therapy with methotrexate under transvaginal ultrasonographic guidance.
Merz E; Bahlmann F; Weber G; Macchiella D; Kruczynski D; Pollow K; Knapstein PG
Gynecol Obstet Invest; 1996; 41(2):76-81. PubMed ID: 8838963
[TBL] [Abstract][Full Text] [Related]
35. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.
Nowak-Markwitz E; Michalak M; Olejnik M; Spaczynski M
Fertil Steril; 2009 Oct; 92(4):1203-1207. PubMed ID: 18851850
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases.
Bonin L; Pedreiro C; Moret S; Chene G; Gaucherand P; Lamblin G
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():23-30. PubMed ID: 27888702
[TBL] [Abstract][Full Text] [Related]
37. Day 1 change in maternal serum β-HCG levels as an early predictor of successful medical therapy in ectopic pregnancies.
Ahmed MR; Sayed Ahmed WA; Mohamed TY
J Matern Fetal Neonatal Med; 2020 Jul; 33(14):2403-2407. PubMed ID: 30608010
[No Abstract] [Full Text] [Related]
38. Comparison of alternative βhCG follow-up protocols after single-dose methotrexate therapy for tubal ectopic pregnancy.
Şükür YE; Koyuncu K; Seval MM; Çetinkaya E; Dökmeci F
Arch Gynecol Obstet; 2017 Dec; 296(6):1161-1165. PubMed ID: 28932897
[TBL] [Abstract][Full Text] [Related]
39. A cohort study to evaluate the effectiveness of laparoscopic-guided local injection of etoposide in the management of women with unruptured tubal pregnancy.
Chen CH; Lee WL; Chiu LH; Sun HD; Liu WM; Wang PH
Fertil Steril; 2011 Sep; 96(3):654-8. PubMed ID: 21737074
[TBL] [Abstract][Full Text] [Related]
40. Assessment of β-human chorionic gonadotropin level as a reliable predictor of tubal patency confirmed with transvaginal ultrasound-guided selective salpingography (TVSSG) following conservative treatment of tubal pregnancy.
Al Sayed I
Arch Gynecol Obstet; 2012 Apr; 285(4):1043-8. PubMed ID: 22002409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
